Monopteros Therapeutics Inc.

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmace

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Newly Public Millendo Advanc

Recent biopharmaceutical initial public offerings show that the IPO boom is not limited to the US, and illustrate the challenges of going public in any market. US stock values have plummeted in recent

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in